Context Therapeutics Inc. — Investor Relations & Filings
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to advancing treatments for solid tumors. The company develops next-generation T cell engaging (TCE) bispecific antibody therapies designed to harness the patient's immune system for targeted cancer eradication. Its pipeline features innovative immunotherapeutic solutions for difficult-to-treat solid tumors. Key portfolio highlights include CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody; CT-95, an avidity-enhanced mesothelin (MSLN) x CD3 bispecific antibody; and CT-202, a dual pH-dependent Nectin-4 x CD3 bispecific antibody.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| ARS - Context Therapeutics Inc. (0001842952) (Filer) | 2026-04-28 | English | |
| 8-K - Context Therapeutics Inc. (0001842952) (Filer) | 2026-04-02 | English | |
| S-8 - Context Therapeutics Inc. (0001842952) (Filer) | 2026-03-23 | English | |
| 8-K - CONTEXT THERAPEUTICS INC. (0001842952) (Filer) | 2026-02-27 | English | |
| 4 - CONTEXT THERAPEUTICS INC. (0001842952) (Filer) | 2026-02-23 | English |
Browse filings by year
6 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cyclerion Therapeutics, Inc.
Develops personalized biofeedback therapies for treatment-r…
|
CYCN | US | Manufacturing |
|
Cyfuse Biomedical K.K.
Develops scaffold-free bio 3D printing technology for tissu…
|
4892 | JP | Manufacturing |
|
CYTOKINETICS INC
A late-stage biopharma developing drugs for diseases of imp…
|
CYTK | US | Manufacturing |
|
CytomX Therapeutics, Inc.
Clinical-stage oncology company developing conditionally ac…
|
CTMX | US | Manufacturing |
|
Cytori Cell Research Institute,Inc.
Develops cell therapy medical devices using a patient's own…
|
3750 | JP | Manufacturing |
|
Daan Gene Co., Ltd.
Specializes in molecular diagnostic products and PCR-based …
|
002030 | CN | Manufacturing |
|
Daebonglsco.,Ltd
Develops and supplies raw materials for the pharmaceutical,…
|
078140 | KR | Manufacturing |
|
DaehanPharmaceutical
Researches, develops, and manufactures human/animal pharma …
|
023910 | KR | Manufacturing |
|
DAE HWA PHARM CO., LTD
Pharmaceutical firm developing drugs with proprietary drug …
|
067080 | KR | Manufacturing |
|
Daesung Microbiological Labs. Co. Ltd
Develops, manufactures, and distributes animal pharmaceutic…
|
036480 | KR | Manufacturing |
Context Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34269/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34269 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34269 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34269 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34269}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Context Therapeutics Inc. (id: 34269)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.